Conox-Guided Anesthesia in Pediatric Adenotonsillectomy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age3-12
SponsorKayseri City Hospital
About this trial
This study aims to evaluate the effect of Conox (qCON/qNOX)-guided anesthesia on intraoperative anesthetic drug consumption and postoperative outcomes in pediatric patients undergoing adenotonsillectomy. Conox is a non-invasive EEG-based monitoring system that provides indices of both hypnosis and nociception.
In this randomized controlled trial, children aged 3-12 years will be assigned to either a Conox-guided anesthesia group or a standard monitoring group. The primary outcome of the study is total intraoperative opioid consumption, assessed from anesthesia induction to the end of surgery. Secondary outcomes include emergence time, extubation time, postoperative agitation, pain scores, and correlation between qCON/qNOX values and hemodynamic parameters.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Design model
Parallel
Treatments tested in this trial
Conox Monitor
DeviceEEG-based monitoring device providing qCON and qNOX indices to guide anesthetic depth and analgesia.
Standard Anesthesia Monitoring
Other interventionAnesthesia management based on conventional clinical parameters such as heart rate and blood pressure.
Treatment groups
128 Participants
are divided into 2 treatment groupsGroup A: Conox GroupExperimental treatment 1 intervention
Group B: Standard Monitoring GroupActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Total Intraoperative Opioid Consumption
Total cumulative opioid dose administered from induction of anesthesia until the end of surgery.
Time frame
Intraoperative periodSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov